Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Cross Timbers Royalty Royalty Trust | CRT | Jan 17, 2025 | 10.28 | -0.48 |
CrossAmerica Partners LP Unit | CAPL | Jan 17, 2025 | 22.63 | -0.79 |
CrossFirst Bankshares | CFB | Jan 17, 2025 | 15.24 | +3.04 |
CrowdStrike A | CRWD | Jan 17, 2025 | 357.00 | -1.76 |
Crown Castle | CCI | Jan 17, 2025 | 91.06 | +0.45 |
Crown Crafts | CRWS | Jan 17, 2025 | 4.52 | -0.44 |
Crown ElectroKinetics | CRKN | Jan 17, 2025 | 0.13 | +56.84 |
Crown Holdings | CCK | Jan 17, 2025 | 85.56 | +0.41 |
Crown LNG | CGBS | Jan 17, 2025 | 0.75 | -0.23 |
Cryo-Cell International | CCEL | Jan 17, 2025 | 7.40 | +5.12 |
CryoPort | CYRX | Jan 17, 2025 | 7.50 | +0.13 |
CS Disco | LAW | Jan 17, 2025 | 4.93 | 0.00 |
CSG Systems International | CSGS | Jan 17, 2025 | 52.85 | +1.48 |
CSP | CSPI | Jan 17, 2025 | 16.25 | +2.98 |
CSW Industrials | CSWI | Jan 17, 2025 | 390.21 | +1.26 |
CSX | CSX | Jan 17, 2025 | 32.73 | -0.73 |
CTO Realty Growth | CTO | Jan 17, 2025 | 19.77 | -0.70 |
CTO Realty Growth A Pref | CTO-A | Jan 17, 2025 | 22.34 | -0.49 |
CTS | CTS | Jan 17, 2025 | 51.64 | +0.49 |
CubeSmart | CUBE | Jan 17, 2025 | 41.36 | -0.31 |
Cue Biopharma | CUE | Jan 17, 2025 | 1.31 | +2.34 |
Cullen Frost Bankers B Pref | CFR-B | Jan 17, 2025 | 18.14 | +0.39 |
Cullen/Frost Bankers | CFR | Jan 17, 2025 | 143.19 | +2.02 |
Cullinan Therapeutics | CGEM | Jan 17, 2025 | 10.26 | +1.18 |
Culp | CULP | Jan 17, 2025 | 5.47 | -2.15 |
Cumberland Pharmaceuticals | CPIX | Jan 17, 2025 | 2.53 | -8.66 |
Cummins | CMI | Jan 17, 2025 | 366.34 | +0.00 |
Cumulus Media A | CMLS | Jan 17, 2025 | 0.84 | -3.45 |
Curbline Properties | CURB | Jan 17, 2025 | 23.54 | +0.04 |
Curevac N.V. | CVAC | Jan 17, 2025 | 4.10 | -1.91 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.